All Stories

  1. Mental distress and health-related quality of life among type 1 and type 2 diabetes patients using self-monitoring of blood glucose: A cross-sectional questionnaire study in Japan
  2. Evaluation of large-scale clinical trials on cardiovascular disease risk in patients with type 2 diabetes mellitus treated with dipeptidyl peptidase 4 inhibitors and a new class of drugs
  3. Long-term glucose lowering effects of sitagliptin monotherapy and dietary contents in Japanese individuals with type 2 diabetes
  4. Therapeutic inertia or individualization? Delay in clinical management of type 2 diabetes mellitus
  5. Glucagon-like peptide-1 receptor agonist therapeutics for total diabetes management: assessment of composite end-points
  6. A case of hypoglycemia due to illegitimate sexual enhancement medication
  7. A case of insulinoma with non-alcoholic fatty liver disease: Roles of hyperphagia and hyperinsulinemia in pathogenesis of the disease
  8. The role of chronobiology and circadian rhythms in type 2 diabetes mellitus: implications for management of diabetes
  9. Relationship and factors responsible for regulating fasting and post‐challenge plasma glucose levels in the early stage development of type 2 diabetes mellitus
  10. Factors influencing the durability of the glucose‐lowering effect of sitagliptin combined with a sulfonylurea
  11. Drug-Induced Generalized Skin Eruption in a Diabetes Mellitus Patient Receiving a Dipeptidyl Peptidase-4 Inhibitor Plus Metformin
  12. Dipeptidyl-peptidase IV inhibitor is effective in patients with type 2 diabetes with high serum eicosapentaenoic acid concentrations
  13. Insulin secretory capacity and insulin sensitivity in impaired fasting glucose in Japanese
  14. Circadian rhythms and diabetes
  15. The Role of Family Nutritional Support in Japanese Patients with Type 2 Diabetes Mellitus
  16. A case of fulminant type 1 diabetes mellitus with exocrine pancreatic insufficiency and enhanced glucagon response to meal ingestion
  17. Up-Regulation of Cell Surface Insulin Receptor by Protein Kinase C-α in Adrenal Chromaffin Cells
  18. BS2-3 Role of insulin secretary capacity in the development of Type 2 diabetes
  19. P-139 The role of family nutritional support in Japanese patients with Type 2 diabetes
  20. Clock gene defect disrupts light-dependency of autonomic nerve activity
  21. Adult pancreatic islets require differential pax6 gene dosage
  22. Factors responsible for deteriorating glucose tolerance in newly diagnosed type 2 diabetes in Japanese men
  23. Effects of thorough mastication on postprandial plasma glucose concentrations in nonobese Japanese subjects
  24. Insulin secretion and insulin sensitivity in Japanese subjects with impaired fasting glucose and isolated fasting hyperglycemia
  25. High Prevalence of Autoantibodies Against Carbonic Anhydrase II and Lactoferrin in Type 1 Diabetes: Concept of Autoimmune Exocrinopathy and Endocrinopathy of the Pancreas
  26. The role of the TSC-22 (−396) A/G variant in the development of diabetic nephropathy
  27. Type-1 diabetes mellitus with insufficient serum immunoreactive insulin elevation after subcutaneous NPH-insulin injection
  28. Impaired β-cell function and insulin sensitivity in Japanese subjects with normal glucose tolerance
  29. Effect of High Dietary Fat on Insulin Secretion in Genetically Diabetic Goto-Kakizaki Rats
  30. Serial change in123I-MIBG myocardial scintigraphy in non-insulin-dependent diabetes mellitus
  31. Oral nicotine administration decreases tumor necrosis factor-alpha expression in fat tissues in obese rats
  32. Up-Regulation of Cell Surface Insulin Receptor by Protein Kinase C-α in Adrenal Chromaffin Cells
  33. 123I-MIBG myocardial scintigraphy in diabetic patients: Relationship with201Tl uptake and cardiac autonomic function
  34. Localization and Functional Role of Synaptotagmin III in Insulin Secretory Vesicles in Pancreatic β-Cells
  35. Fusion of Insulin Receptor Ectodomains to Immunoglobulin Constant Domains Reproduces High-affinity Insulin Bindingin Vitro
  36. Selective impairment of the cytoplasmic Ca2+ response to glucose in pancreatic β cells of streptozocin-induced non-insulin-dependent diabetic rats
  37. Suppressive effect of GABA on insulin secretion from the pancreatic beta-cells in the rat
  38. Short Term Effects of Glucose and Arginine on the Preproinsulin Messenger Ribonucleic Acid Level in the Perfused Rat Pancreas: Comparison with Insulin Secretion
  39. Characteristic features of insulin secretion in the streptozotocin-induced NIDDM rat model
  40. The effect of mazindol on insulin and glucagon secretion in rats with ventromedial hypothalamic obesity
  41. Successful treatment of the crisis of scleroderma with enalapril maleate (MK-421).